Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Amortization of Deferred Charges (2020 - 2022)

Insight Molecular Diagnostics (IMDX) has disclosed Amortization of Deferred Charges for 3 consecutive years, with $1000.0 as the latest value for Q3 2022.

  • Quarterly Amortization of Deferred Charges fell 92.31% to $1000.0 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $12000.0 through Dec 2022, down 78.57% year-over-year, with the annual reading at $12000.0 for FY2022, 78.57% down from the prior year.
  • Amortization of Deferred Charges hit $1000.0 in Q3 2022 for Insight Molecular Diagnostics, down from $4000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $35000.0 in Q1 2020 to a low of $1000.0 in Q3 2022.
  • Historically, Amortization of Deferred Charges has averaged $15454.5 across 3 years, with a median of $14000.0 in 2021.
  • Biggest five-year swings in Amortization of Deferred Charges: tumbled 36.36% in 2021 and later crashed 92.31% in 2022.
  • Year by year, Amortization of Deferred Charges stood at $22000.0 in 2020, then tumbled by 54.55% to $10000.0 in 2021, then tumbled by 90.0% to $1000.0 in 2022.
  • Business Quant data shows Amortization of Deferred Charges for IMDX at $1000.0 in Q3 2022, $4000.0 in Q2 2022, and $7000.0 in Q1 2022.